Monday, December 5, 2022
News

Covaxin to be evaluated as COVID-19 vaccine candidate in US: Bharat Biotech

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

Hyderabad (Telangana) | February 19, 2022 8:20:51 PM IST
Hyderabad-based Bharat Biotech on Saturday said its COVID-19 vaccine Covaxin will be evaluated as a vaccine candidate for the disease in the United States.

"Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the Company's Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States. Ocugen, Inc is co-developing Bharat Biotech's Covaxin vaccine candidate for COVID-19 in USA and Canada," reads Bharat Biotech's statement.

Earlier the Ministry of Health and Family Welfare had informed that Covaxin has been granted approval for emergency use in 13 countries as of January 31, 2022. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Anti-Constitution remark: Police to clos...
BJP is sabotaging UP's Lok Sabha bypoll:...
Mainpuri bypolls: Akhilesh Yadav, Dimple...
50% voter turnout in MCD polls...
OPS, EPS to hold separate meetings to ma...
Cong leader files complaint against Ajma...
More...    
 
 Top Stories
Mainpuri bypolls: Voter turnout 7.0... 
Operations, safety processes found ... 
"I see a change of 27-year-long BJP... 
G20: Amitabh Kant holds talks with ... 
Gujarat polls: Hardik Patel casts v... 
7 dead as truck crushes bystanders ... 
Gujarat polls second phase: Voter t... 
Bihar: Voters que up to vote for Ku...